| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type |
| 2013 | Half-lives of 221Fr, 217At, 213Bi, 213Po and 209Pb from the 225Ac decay series | SULIMAN GABRIEL; POMME Stefaan; MAROULI Maria; VAN AMMEL Raf; STROH HEIKO; JOBBAGY Viktor; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos, et al | Articles in Journals |
| 2000 | High-Linear Energy Transfer (LET) alpha vs Low-LET beta Emitters in Radioimmunotherapy of Solid Tumors: Therapeutic Efficacy and Dose-Limiting Toxicity of 213Bi- vs 90Y-Labeled CO17-1A Fab' Fragments in a Human Colonic Cancer Model. | BEHR T.m.; BEHE M.; STABIN M.g.; WEHRMANN E.; APOSTOLIDIS Christos; MOLINET Roger; STRUTZ F.; FAYYAZI A.; WIELAND E.; GRATZ S.t., et al | Articles in Journals |
| 2012 | High-resolution alpha-particle spectrometry of the 230U decay series | MAROULI MARIA; POMME Stefaan; PAEPEN Jan; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN ABDULLAH; SULIMAN GABRIEL; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel, et al | Contributions to Conferences |
| 2001 | Highly Specific Tumor Binding of a 213Bi Labeled Monoclonal Antibody against Mutant E-Cadherin Suggests its Usefulness for Locoregional alpha-Radioimmunotherapy of Diffuse-Type Gastric Cancer. | SENEKOWITSCH-SCHMIDTKE R.; SCHUHMACHER C.; BECKER K.; NIKULA T.k.; SEIDL C.; BECKER I.; MIEDERER M.; APOSTOLIDIS Christos; ADAM C.; HUBER Roswitha, et al | Articles in Journals |
| 1997 | Homoscorpionates (Hydridotris(1-pyrazoly)borato Complexes) of the Trivalent 4f Ions. The Crystal and Molecular Structure of ((HB(N2C3H3)3)3LnIII, (Ln=Pr,Nd). | APOSTOLIDIS Christos; REBIZANT Jean; VON AMMON R.; DORNBERGER Ernst; MUELLER J.; POWIETZKA B.; NUBER B. | Articles in Journals |
| 2004 | Importance of Receptor Density in Alpha Radioimmunotherapy in B Cell Malignancies: an In-vitro Study. | VANDENBULCKE Katja; THIERENS H.; OFFNER Fritz; JANSSENS A.; DE GELDER V.; BACHER K.; PHILIPPE Jan; DE VOS F.; DIERCKX R.; APOSTOLIDIS Christos, et al | Articles in Journals |
| 2007 | An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha Therapy | ZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED | Articles in Journals |
| 2009 | In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapy | BRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS Christos | Contributions to Conferences |
| 2003 | In Vitro Evaluation of 231Bi-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage. | VANDENBULCKE K.; DE VOS F.; OFFNER Fritz; PHILIPPE Jan; APOSTOLIDIS Christos; MOLINET Roger; NIKULA T.k.; BACHER K.; DE GELDER V.; VRAL A., et al | Articles in Journals |
| 2005 | In Vitro Evaluation of High-LET 213Bi-Therapy Combined to Other Therapeutic Agents for the Treatment of B-CLL. | VANDENBULCKE Katja; THIERENS H.; DE VOS F.; PHILIPPE Jan; OFFNER Fritz; APOSTOLIDIS Christos; MORGENSTERN A.; BACHER K.; DE GELDER V.; DIERCKX R., et al | Articles in Journals |
| 2006 | In Vitro Screening for Synergism of High-linear Energy Transfer 213Bi-radiotherapy with other Therapeutic Agents for the Treatment of B-cell Chronic Lymphocytic Leukemia | VANDENBULCKE K.; THIERENS H.; VOS F.d.; OFFNER F.; JANSSENS F.; PHILIPPE J.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; BACHER K.; DE GELDER V., et al | Articles in Journals |
| 2009 | Inhibition ofMicrometastatic Prostate Cancer Cell Spread in Animal Models By 213BilabeledMultipleTargeted Alpha-Radioimmunoconjugates | LI Y.; SONG E.; ABBAS RIZVI S. M.; POWER C. A.; BERETOV J.; RAJA C.; COZZI P. J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; ALLEN B. J., et al | Articles in Journals |
| 2006 | Interaction of Radiolabeled Antibodies with Fungal Cells and Components of Immune System In Vitro and During Radioimmunotherapy of Experimental Fungal Infection | DADACHOVA E.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; ZHANG T.; MOADEL T.; CASADEVALL A. | Articles in Journals |
| 2007 | Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma | RAJA C.; GRAHAM P.; ABBAS RIZVI S. M.; SONG E.; GOLDSMITH H.; THOMPSON J.; BOSSERHOFF A.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; KEARSLEY J., et al | Articles in Journals |
| 2005 | Intralesional Targeted Alpha Therapy for Metastatic Melanoma | ALLEN Barry J.; RAJA C.; RIZVI S.m.a.; LI Y.; TSUI W.; GRAHAM P.; THOMPSON J.; REISFELD R.a.; KEARSLEY J.; MORGENSTERN ALFRED, et al | Articles in Journals |
| 2010 | Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230U | MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred | Articles in Journals |
| 2010 | Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U† | MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred | Articles in Journals |
| 2006 | Local Trageting of Malignant Gliomas by the Difussible Peptidic Vector DOTAGA-substance P | KNEIFEL S.; CORDIER D.; GOOD S.; IONESCU M.; GHAFFARI A.; HOFER S.; KRETSCHMAR M.; TOLNAY M.; APOSTOLIDIS CHRISTOS; WASER B; ARNOLD M.; MUELLER-BRAND J.; MAECKE H.r.; REUBI J.c.; MERLO A. | Articles in Journals |
| 2001 | Lysine Protection against Bismuth Accumulation in the Kidneys when Using 213-Bi-DTPA-MAB. | NIKULA T.; APOSTOLIDIS Christos; MOLINET Roger; CARLOS-MARQUEZ R.; BRANDES K.; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2011 | Magnetic Memory Effect in a Transuranic Mononuclear Complex | MAGNANI Nicola; APOSTOLIDIS Christos; MORGENSTERN Alfred; COLINEAU Eric; GRIVEAU Jean-Christophe; BOLVIN Hélène; WALTER OLAF; CACIUFFO Roberto | Articles in Journals |
